Pfizer CentreOne is an award winning global CDMO that leverages Pfizer’s extensive scientific and technical expertise to manufacture medicines for pharmaceutical and biotech companies. They offer a wide range of contract development & manufacturing services including small to large scale production for oral solids, sterile injectables, small molecules, biologics, and regulatory services. The company's cutting-edge development and commercial manufacturing solutions cater to diverse needs in the biotechnology, manufacturing, and pharmaceutical industries. Although the founding date and headquarters location are unavailable, Pfizer CentreOne is a promising investment opportunity for venture capitalists looking to invest in the pharmaceutical and biotech manufacturing sector. With their strong track record and wide range of services, Pfizer CentreOne presents substantial potential for growth and success. Visit www.pfizercentreone.com for more information. Note: External links found in posts on this page are neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of external sites.
There is no investment information
No recent news or press coverage available for Pfizer CentreOne.